As aberrant BRCA1 promoter methylation is found in approximately 10% of sporadic breast cancers (Shakeri et al, 2016), we first measured the levels of epigenetic silencing of BRCA1 and analyzed BRCA1 expression and nuclear foci formation in PDX samples. Here, BRCA1 is linked to breast carcinoma.